🔎 Trials Near Me

Hjem › Crohns sykdom › Missouri › St. Louis

Kliniske studier for Crohns sykdom i St. Louis, MO

19 studier for Crohns sykdom søker deltakere på steder i og rundt St. Louis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RekruttererFase 2
  • Specialists In Gastroenterology /ID# 283939, St Louis
Alder 18 til 75 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

RekruttererFase 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • og 1 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekruttererFase 3
  • Washington University School of Medicine ( Site 5058), St Louis
Alder 16 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RekruttererFase 4
  • SSM Health Medical Group, Bridgeton · 15 mi unna
Alder 18 til 80 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RekruttererFase 2
  • Washington University /ID# 266938, St Louis
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06548542

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekruttererFase 3
  • Washington University School of Medicine, St Louis
Alder 18 til 70 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • Washington University School of Medicine-Site Number: 8400075, St Louis
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Alder 16 til 80 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Alder 16 til 80 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07184944

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

RekruttererFase 3
  • Washington University School of Medicine, St Louis
Alder 2 til 19 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

RekruttererFase 2
  • KAD Clinical Research, St Louis
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

RekruttererFase 2
  • SSM Health DePaul Hospital- St. Louis, Bridgeton · 15 mi unna
Alder 18 til 85 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

RekruttererFase 2
  • KAD Clinical Research, St Louis
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

RekruttererFase 4
  • Washington University School of Medicine, St Louis
Alder 18 til 70 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06045754

DB-3Q for the Treatment of Medically Refractory Crohn's Disease

RekruttererFase 2
  • Washington University, St. Louis, St Louis
Alder 18 til 75 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07625293

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

RekruttererFase 2
  • Washington University School of Medicine, St Louis
Alder 18 til 80 · Alle kjønn · Oppdatert 5. jun. 2026 · NCT06976853

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

RekruttererFase 2
  • Investigational Site Number: 8400013, St Louis
Alder 18 til 75 · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekruttererFase 2
  • Mirador Therapeutics Selected Site, Bridgeton · 15 mi unna
Alder 18 til 80 · Alle kjønn · Oppdatert 12. mar. 2026 · NCT07113522

Treatment of Moderate to Severe Refractory Crohn's Disease

RekruttererFase 1/2
  • Washington University in St. Louis, St Louis
Alder 18 til 65 · Alle kjønn · Oppdatert 10. des. 2025 · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

RekruttererObservasjonsstudie
  • Washington University in St Louis School of Medicine, St Louis
Alder 18 og eldre · Alle kjønn · Oppdatert 12. nov. 2025 · NCT06670638

Crohns sykdom-studier i andre byer

Andre studier i St. Louis

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.